Abstract:Mitochondria, a cellular metabolic center, efficiently fulfill cellular energy needs and regulate crucial metabolic processes, including cellular proliferation, differentiation, apoptosis, and generation of reactive oxygen species. Alteration in the mitochondrial functions leads to metabolic imbalances and altered extracellular matrix dynamics in the host, utilized by solid tumors like pancreatic cancer (PC) to get energy benefits for fast‐growing cancer cells. PC is highly heterogeneous and remains unidentified for a longer time because of its complex pathophysiology, retroperitoneal position, and lack of efficient diagnostic approaches, which is the foremost reason for accounting for the seventh leading cause of cancer‐related deaths worldwide. PC cells often respond poorly to current therapeutics because of dense stromal barriers in the pancreatic tumor microenvironment, which limit the drug delivery and distribution of antitumor immune cell populations. As an alternative approach, various natural compounds like flavonoids are reported to possess potent antioxidant and anticancerous properties and are less toxic than current chemotherapeutic drugs. Therefore, we aim to summarize the current state of knowledge regarding the pharmacological properties of flavonols in PC in this review from the perspective of mitigating mitochondrial dysfunctions associated with cancer cells. Our literature survey indicates that flavonols efficiently regulate cellular metabolism by scavenging reactive oxygen species, mitigating inflammation, and arresting the cell cycle to promote apoptosis in tumor cells via intrinsic mitochondrial pathways. In particular, flavonols proficiently inhibit the cancer‐associated proliferation and inflammatory pathways such as EGFR/MAPK, PI3K/Akt, and nuclear factor κB in PC. Overall, this review provides in‐depth evidence about the therapeutic potential of flavonols for future anticancer strategies against PC; still, more multidisciplinary human interventional studies are required to dissect their pharmacological effect accurately.

Flavonoids as modulators of miRNA expression in pancreatic cancer: Pathways, Mechanisms, And Therapeutic Potential

Molecular Mechanisms and Clinical Applications of Mir-22 in Regulating Malignant Progression in Human Cancer (Review)

Flavonoid display ability to target microRNAs in cancer pathogenesis

Role of bio‐flavonols and their derivatives in improving mitochondrial dysfunctions associated with pancreatic tumorigenesis

MiRNAs Directly Targeting the Key Intermediates of Biological Pathways in Pancreatic Cancer

Unlocking the potential of flavonoids: Natural solutions in the fight against colon cancer

MicroRNAs: emerging biomarkers and therapeutic targets in pancreatic cancer

Targeting epigenetics in cancer: therapeutic potential of flavonoids

MicroRNA-222 Controls Human Pancreatic Cancer Cell Line Capan-2 Proliferation by P57 Targeting.

Molecular Mechanism of Curcumin and Its Analogs as Multifunctional Compounds against Pancreatic Cancer

Flavonoids Nanoparticles in Cancer: Treatment, Prevention and Clinical Prospects.

mTor Targeting by Different Flavonoids for Cancer Prevention

Quercetin Impact in Pancreatic Cancer: An Overview on Its Therapeutic Effects

Flavonoids nanoparticles in cancer: Treatment, prevention and clinical prospects

Molecular Pathways Involved in the Anti-Cancer Activity of Flavonols: A Focus on Myricetin and Kaempferol

mTOR Targeted Cancer Chemoprevention by Flavonoids

Flavonoids against the Warburg phenotype-concepts of predictive, preventive and personalised medicine to cut the Gordian knot of cancer cell metabolism

Dietary Phytochemicals in Cancer Signalling Pathways: Role of miRNA Targeting

Epigallocatechin-3-gallate and cancer: focus on the role of microRNAs

Flavonoid Nanoparticles: A Promising Approach for Cancer Therapy

Dietary flavonoids: Nano delivery and nanoparticles for cancer therapy